5 European Dividend Aristocrats Offer Huge Growth and Income Potential With Diversification From the US24/7 Wall Street • 04/13/23
Why 7 of the Highest-Yielding ‘Strong Buy' Health Care Stocks Are the Absolute Best 2023 Buys24/7 Wall Street • 04/12/23
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreementsGlobeNewsWire • 04/11/23
Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.GlobeNewsWire • 04/10/23
Press Release: Two fitusiran Phase 3 studies published in The Lancet and The Lancet Haematology highlight potential to address unmet needs across all types of hemophiliaGlobeNewsWire • 04/04/23
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVBBusiness Wire • 03/29/23
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi SoarsInvestors Business Daily • 03/23/23
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPDCNBC • 03/23/23